Poland· PL-100416690
Delstrigo
A lamivudine, tenofovir disoproxil and doravirine product containing doravirinum + lamivudinum + tenofovirum disoproxilum, registered in Poland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lamivudine, tenofovir disoproxil and doravirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR24 (lamivudine, tenofovir disoproxil and doravirine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Lamivudine, tenofovir disoproxil and doravirine · ATC J05AR24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Doravirinum + Lamivudinum + Tenofovirum disoproxilum
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Poland (PL)
- ATC code
- J05AR24
- ATC class
- Lamivudine, tenofovir disoproxil and doravirine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin00191778021578
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine, tenofovir disoproxil and doravirine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELSTRIGOMerck Sharp & Dohme B.V., Haarlem
- FinlandDelstrigoMerck Sharp & Dohme B.V.
- United StatesDELSTRIGOMerck Sharp & Dohme LLC
- CanadaDELSTRIGOMERCK CANADA INC
- IrelandDelstrigo 100 mg/300 mg/245 mg film-coated tabletsMerck Sharp & Dohme BV,
- IcelandDelstrigoMerck Sharp & Dohme B.V.*
- NorwayDelstrigoMerck Sharp & Dohme Ltd (1)
- SwedenDelstrigo 100 mg/300 mg/245 mg Filmdragerad tablettMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Delstrigo
- Liechtenstein · Delstrigo
- Norway · Delstrigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/072e1681-c6d9-49ee-aaa9-4948919c7cde GET /v1/drugs/072e1681-c6d9-49ee-aaa9-4948919c7cde?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg + 300 mg + 245 mg",
"packaging": "00191778021578 ¦ Rpz ¦ EU/1/18/1333/001 ¦ 131314\n30 tabl.\nRpz ¦ EU/1/18/1333/002 ¦ 131315\n90 tabl. (op. zbiorcze)",
"substance": "Doravirinum 100 mg + Lamivudinum 300 mg + Tenofovirum disoproxilum 245 mg",
"common_name": "Doravirinum + Lamivudinum + Tenofovirum disoproxilum",
"pl_product_id": "100416690",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about lamivudine, tenofovir disoproxil and doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.